Literature DB >> 122040

Secondary prevention of ischemic heart disease: a long-term controlled lidoflazine study.

H De Geest, H Kesteloot, J Piessens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 122040

Source DB:  PubMed          Journal:  Acta Cardiol Suppl        ISSN： 0373-7934


× No keyword cloud information.
  5 in total

Review 1.  Antiarrhythmic therapies for the prevention of sudden cardiac death.

Authors:  F A McAlister; K K Teo
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

2.  Effects of calcium channel blockers on survival after myocardial infarction.

Authors:  S Yusuf; C D Furberg
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 3.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

4.  Treatment with verapamil after an acute myocardial infarction. Review of the Danish studies on verapamil in myocardial infarction (DAVIT I and II).

Authors:  J F Hansen
Journal:  Drugs       Date:  1991       Impact factor: 9.546

5.  Lidoflazine in the early stages of acute myocardial ischaemia.

Authors:  S J Coker; O Fagbemi; J R Parratt
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.